Clinical Liver Disease
Nonalcoholic fatty liver disease: Indications for liver biopsy and noninvasive biomarkers - Mazen Noureddin and Rohit Loomba – Article Reading
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:06:25
- Mas informaciones
Informações:
Sinopsis
Liver biopsy is the gold standard to confirm NASH, a progressive form of NAFLD. Biomarkers and clinical prediction rules for refining the management paradigm of NAFLD are emerging. Drs. Noureddin and Loomba discuss the noninvasive biomarkers that may be useful and indications for performing liver biopsy in patients with NAFLD.
